EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Butyrate acts as a positive allosteric modulator of the 5‐HT transporter to decrease availability of 5‐HT in the ileum

Jieling Cai, Jamie Cheung, Samson W M Cheung, Karie T C Chin, Ricky W K Leung, Ronald S T Lam, Rakesh Sharma, Jensen H C Yiu, Connie W Woo iD

British Journal of Pharmacology · 2024-06 · 181 (11) · 1654-1670

DOI: 10.1111/bph.16305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 05.02.2024. Verfasst von Jieling Cai und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Ileum, Serotonin, Butyrates, Gastrointestinal Microbiome. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: HKU Internal Seed Fund for Basic Research, Hong Kong Research Grant Council, Hong Kong RGC Postdoctoral Fellowship Scheme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Radiation therapy‐induced gastrointestinal distress is partly associated with the elimination of gut microbiota. The effectiveness of 5‐HT receptor antagonists to treat radiation therapy‐induced emesis implies a pathophysiological role of 5‐HT. Peripheral 5‐HT is derived from intestinal epithelium. We have investigated the role of gut microbiota in regulating intestinal 5‐HT availability. Experimental Approach A radiation therapy murine model accompanied by faecal microbiota transplantation from donors fed different diets was investigated, and mouse ileal organoids were used for mechanistic studies. The clinical relevance was validated by a small‐scale human study. Key Results Short‐term high‐fat diet (HFD) induced gut bacteria to produce butyrate. Irradiated mice receiving HFD‐induced microbiome had the lowest ileal levels of 5‐HT, compared with other recipients. Treatment with butyrate increased 5‐HT uptake in mouse ileal organoids, assayed by the real‐time tracking of a fluorescent substrate for monoamine transporters. Silencing the 5‐HT transporter (SERT) in the organoids abolished butyrate‐stimulated 5‐HT uptake. The competitive tests using different types of selective 5‐HT reuptake inhibitors suggested that butyrate acted as a positive allosteric modulator of SERT. In human gut microbiota, butyrate production was associated with the interconversion between acetate and butyrate. Faecal contents of both acetate and butyrate were negatively associated with serum 5‐HT, but only butyrate was positively correlated with body mass index in humans. Conclusion and Implications Short‐term HFD may be beneficial for alleviating gastrointestinal reactions by increasing butyrate to suppress local 5‐HT levels and providing energy to cancer patients given radiation therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IleumSerotoninButyratesGastrointestinal MicrobiomeSerotonin Plasma Membrane Transport ProteinsMice, Inbred C57BLAnimalsHumansMiceAllosteric RegulationMaleFecal Microbiota TransplantationDiet, High-FatOrganoids

Stichwörter der Autor:innen

5‐HT (serotonin)5‐HT transporterbutyrateileumradiation therapyshort‐term high‐fat diet

Substanzen

SerotoninButyratesSerotonin Plasma Membrane Transport Proteins

Autor:innen und Institutionen

  • State Key Laboratory of Pharmaceutical Biotechnology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Centre for PanorOmic Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Micon Analytics, Toronto, Canada.

ORCID-Profile: Connie W Woo

Förderung

  • HKU Internal Seed Fund for Basic Research
  • Hong Kong Research Grant Council
  • Hong Kong RGC Postdoctoral Fellowship Scheme

Zitieren

APA

Cai, J., Cheung, J., Cheung, S. W. M., Chin, K. T. C., Leung, R. W. K., Lam, R. S. T., Sharma, R., Yiu, J. H. C., & Woo, C. W. (2024). Butyrate acts as a positive allosteric modulator of the 5‐HT transporter to decrease availability of 5‐HT in the ileum. British Journal of Pharmacology, 181(11), 1654-1670. https://doi.org/10.1111/bph.16305

Vancouver

Cai J, Cheung J, Cheung SWM, Chin KTC, Leung RWK, Lam RST, et al. Butyrate acts as a positive allosteric modulator of the 5‐HT transporter to decrease availability of 5‐HT in the ileum. British Journal of Pharmacology. 2024;181(11):1654-1670. doi:10.1111/bph.16305

BibTeX
@article{Cai2024,
  author = {Cai, Jieling and Cheung, Jamie and Cheung, Samson W M and Chin, Karie T C and Leung, Ricky W K and Lam, Ronald S T and Sharma, Rakesh and Yiu, Jensen H C and Woo, Connie W},
  title = {Butyrate acts as a positive allosteric modulator of the 5‐HT transporter to decrease availability of 5‐HT in the ileum},
  journal = {British Journal of Pharmacology},
  year = {2024},
  volume = {181},
  number = {11},
  pages = {1654--1670},
  doi = {10.1111/bph.16305}
}
Kostenlos starten →